Syngen Biotech Co Ltd operates in the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Syngen Biotech Co Ltd with three other
companies in this sector in TAIWAN :
Chunghwa Chemical Synthesis & Biotech Co Ltd
sales of 1.16 billion Taiwanese Dollars [US$40.22 million]
of which 54%
Savior Lifetec Corp
(1.32 billion Taiwanese Dollars [US$45.85 million]
of which 100%
was Drugs Development, Production and Sales), and
Panion & Bf Biotech Inc.
(1.57 billion Taiwanese Dollars [US$54.73 million]
of which 77%
Syngen Biotech Co Ltd reported sales of 1.30 billion Taiwanese Dollars (US$45.11 million)
December of 2019.
increase of 20.1%
versus 2018, when the company's sales were 1.08 billion Taiwanese Dollars .
Sales at Syngen Biotech Co Ltd have increased during each of the previous five years
(and since 2014, sales have increased a total of 133%).
Sales of Functional Food and Mupirocin saw an increase
20.3% in 2019, from
1.07 billion Taiwanese Dollars to 1.29 billion Taiwanese Dollars .
Not all segments of Syngen Biotech Co Ltd experienced an increase in sales in 2019:
sales of Other fell 3.3% to 9.10 million Taiwanese Dollars .
(However, this segment's sales were only a very small portion of the company's overall sales).